Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/4876
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZhao, Yiying-
dc.contributor.authorJiang, Qing-
dc.date.accessioned2023-06-13T05:00:07Z-
dc.date.available2023-06-13T05:00:07Z-
dc.date.issued2021-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/4876-
dc.description.abstractAccumulating evidence indicates that the gut microbiota can promote or inhibit colonic inflammation and carcinogenesis. Promotion of beneficial gut bacteria is considered a promising strategy to alleviate colonic diseases including colitis and colorectal cancer. Interestingly, dietary polyphenols, which have been shown to attenuate colitis and inhibit colorectal cancer in animal models and some human studies, appear to reach relatively high concentrations in the large intestine and to interact with the gut microbial community. This review summarizes the modulatory effects of polyphenols on the gut microbiota in humans and animals under healthy and diseased conditions including colitis and colitis-associated colorectal cancer (CAC). Existing human and animal studies indicate that polyphenols and polyphenol-rich whole foods are capable of elevating butyrate producers and probiotics that alleviate colitis and inhibit CAC, such as Lactobacillus and Bifidobacterium. Studies in colitis and CAC models indicate that polyphenols decrease opportunistic pathogenic or proinflammatory microbes and counteract disease-induced dysbiosis. Consistently, polyphenols also change microbial functions, including increasing butyrate formation. Moreover, polyphenol metabolites produced by the gut microbiota appear to have anticancer and anti-inflammatory activities, protect gut barrier integrity, and mitigate inflammatory conditions in cells and animal models. Based on these results, we conclude that polyphenol-mediated alteration of microbial composition and functions, together with polyphenol metabolites produced by the gut microbiota, likely contribute to the protective effects of polyphenols on colitis and CAC. Future research is needed to validate the causal role of the polyphenol–gut microbiota interaction in polyphenols’ anti-colitis and anti-CAC effects, and to further elucidate mechanisms underlying such interaction.en_US
dc.language.isoen_USen_US
dc.publisherAdvances in Nutritionen_US
dc.relation.ispartofseriesReview;546-565-
dc.subjectpolyphenolen_US
dc.subjectcolitisen_US
dc.subjectcolitis-associated colorectal canceren_US
dc.subjectchemopreventionen_US
dc.subjectgut microbiotaen_US
dc.subjectshort-chain fatty acidsen_US
dc.subjectprobioticsen_US
dc.subject16S rRNAen_US
dc.titleRoles of the Polyphenol–GutMicrobiota Interaction in Alleviating Colitis and Preventing Colitis-Associated Colorectal Canceren_US
dc.typeArticleen_US
Appears in Collections:VOL 12 NO 2 (2021)

Files in This Item:
File Description SizeFormat 
546-565.pdf510.43 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.